Documento fuente o registro público

FDA 510(k) K192730 — CALCIUM-CRESOLPHTHALEIN, GLUCOSE, UREA/BUN-UV

FDA 510(k) index record K192730. Device: CALCIUM-CRESOLPHTHALEIN, GLUCOSE, UREA/BUN-UV. Applicant as listed: Biosystems S.A.. Decision date: 2020-09-09.

OtherU.S. Food and Drug Administration (FDA)2020-09-09

Fuente

"device_name": "CALCIUM-CRESOLPHTHALEIN, GLUCOSE, UREA/BUN-UV"

Esta entrada describe lo que cubre el documento; el propio documento es la autoridad. Incluirlo no implica estar de acuerdo con sus conclusiones.

Review and references

Reviewer

Automated FDA record verification

Published

2026-10-20

Updated

2026-10-20

Disclaimer

professional use

FDA 510(k) public index record K192730.

Device name: CALCIUM-CRESOLPHTHALEIN, GLUCOSE, UREA/BUN-UV. Applicant as listed: Biosystems S.A..

Decision date: 2020-09-09. Decision wording: Substantially Equivalent.

Product code: CHW. Regulation: 21 CFR 862.1145. Medical specialty: Clinical Chemistry.

This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.

Interested in these solutions?

Submit a sourcing request with the assays, volumes, and timeline of your own project.

Explorar más